Design, synthesis, and antitumor activity evaluation of potent fourth-generation EGFR inhibitors for treatment of Osimertinib resistant non-small cell lung cancer (NSCLC)
Yuchen Zhang & Lexian Tong & Fangjie Yan & Ping Huang & Cheng-Liang Zhu & Chenghao Pan
